On Thursday, July 19th, NCHAM will be hosting the webinar: “Clinical and Hearing Management of Infants Identified on Cytomegalovirus (CMV) Screening with Congenital CMV Infection – What to do With all the Babies?” presented by Karen Fowler. Read more about the webinar.
When: Thursday, July 19, 2018
12:00 pm - 1:00 pm PACIFIC TIME ZONE
1:00 pm - 2:00 pm MOUNTAIN TIME ZONE
2:00 pm - 3:00 pm CENTRAL TIME ZONE
3:00 pm - 4:00 pm EASTERN TIME ZONE
Where: Online via Adobe Connect
Live captioning will also be provided; a link will be available for captioning upon logging into the webinar.
With increasing interest in screening for congenital CMV infection (cCMV), many more children with cCMV are being identified. Implementation of targeted CMV screening, within newborn hearing screening, in multiple states along with individual hospitals elsewhere is leading to identification of infants with cCMV that would have previously gone undetected. Approximately 15% of clinically inapparent (asymptomatic) cCMV infants will have hearing loss during early childhood years but less is known about developmental disabilities in the asymptomatic cCMV infant. Current clinical and antiviral treatment recommendations apply to infants with symptomatic cCMV. However, it is unclear what the appropriate clinical evaluation and management is for the asymptomatic cCMV infant who is at risk for CMV sequelae, although to a lesser degree than the infants with symptomatic disease. How should the asymptomatic infant with isolated hearing loss at birth or an infant with asymptomatic infection with no hearing loss at birth be clinically managed? Should all asymptomatic infants undergo full laboratory and neuroimaging evaluations? Is there evidence for treatment of infants with asymptomatic cCMV with antivirals? How often should cCMV infants or children have audiological assessments and until what age? This session will summarize the current literature, data from UAB's earlier cohort and the CHIMES study to develop a proposed clinical management and hearing algorithm for the asymptomatic cCMV infant. In addition, we will address the gaps in our knowledge where more data are needed for the clinical management of infants with asymptomatic cCMV.
Karen B. Fowler, DrPH, is a professor in the Department of Pediatrics at the UAB School of Medicine. Her research focuses on the epidemiology, natural history, and pathogenesis of maternal and congenital cytomegalovirus infections and CMV-related hearing loss in children.